Teva Pharmaceuticals
TEVA
TEVA
422 hedge funds and large institutions have $5.05B invested in Teva Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 130 increasing their positions, 142 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 12 → 12 (0)
8% less repeat investments, than reductions
Existing positions increased: 130 | Existing positions reduced: 142
2% less funds holding
Funds holding: 429 → 422 (-7)
Holders
422
Holding in Top 10
12
Calls
$332M
Puts
$330M
Top Buyers
| 1 | +$102M | |
| 2 | +$50.7M | |
| 3 | +$47.4M | |
| 4 |
GAM
Goldentree Asset Management
New York
|
+$22.7M |
| 5 |
LIM
Lingotto Investment Management
London,
United Kingdom
|
+$21.8M |
Top Sellers
| 1 | -$72.7M | |
| 2 | -$37.5M | |
| 3 | -$21.9M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$18.2M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$17.9M |